Pacific Biosciences of California (PACB) — Capital Reinvestment Ratio
Pacific Biosciences of California (PACB) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($75.36 Million) in capital expenditures ($117.00K). See debt-free asset ratio of Pacific Biosciences of California to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pacific Biosciences of California Capital Reinvestment Ratio (2020–2020)
This chart tracks Pacific Biosciences of California's Capital Reinvestment Ratio across 1 annual periods. Check PACB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pacific Biosciences of California (2020–2020)
Year-by-year Capital Reinvestment Ratio for Pacific Biosciences of California from 2020 to 2020. For live market cap and broader valuation context, see PACB market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $19.50 Million | $1.04 Million | — |